Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triferic AVNU Dosing Schedules PK Study
NCT04409132Phase 2Completed
- Sponsor
- Rockwell Medical
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ferric pyrophosphate in anemia of chronic kidney disease (CKD-A), sponsored by Rockwell Medical. Started Jun 2020; status: completed.
02
Drugs
ferric pyrophosphate
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04409132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04409132.